- Home
- Equipment
- asia middle east
- targeted boron drugs
Show results for
Refine by
Targeted Boron Drugs Equipment Supplied In Asia Middle East
35 equipment items found
Manufactured by:EirGenix, Inc based inNew Taipei City, TAIWAN
Product: TSY0110 (EG12043) Antibody-Drug Conjugate. Indication: Cancer. Target: HER2. Status: ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
Agonist refers to substances that activate a specific target protein. It can easily be viewed as the opposite of inhibitor. Until now, Deargen's drug-target interaction (DTI) was predicted based on the binding affinity between the substance and the target protein, which causes barrier to distinguish between the inhibition and activation activity. In addition, the demand for agonist hit discovery ...
by:Onegene Biotechnology based inSuwon, SOUTH KOREA
Onegene Biotechnology is pioneering multi-target therapeutics to create breakthrough medicines that will transform the lives of people with complex and chronic diseases. Onegene’s proprietary platform, UniStac®, allows rapid expansion of promising combinations of the targets into a single multi-target molecule with enzyme-mediated protein-protein conjugation technology while removing ...
Manufactured by:Biosensors International Group, Ltd. based inSingapore, SINGAPORE
BA9, an effective Cytostatic Limus Drug: Rapid 28 day BA9 transfer to the vessel wall achieved through enhanced high lipophilicity delivering: Greater Local Bioavailability. Targeted Drug Release. Local tissue warehousing allowing Sustained Tissue Release, with Therapeutic Effect up to 100 days12,13. Longer Half Life than other commonly used Limus Drugs, approximately 20 days in tissue12,13. ...
Manufactured by:Concept Medical Inc. based inTampa, FLORIDA (USA)
Conversion of Sirolimus drug into sub-micron sized particles; Nanocarriers created by encapsulation of sub-micron sized Sirolimus drug into highly biocompatible drug Carrier-phospholipid; Upon inflation of MagicTouch SCB at target site, nanocarriers with Sirolimus drug inside gets transferred to the vessel wall following the principle of co-efficient diffusion; Upon body pH variation, ...
by:Xiamen Spacegen Co., Ltd. based inxiamen, CHINA
Detection Gene:BCR-ABL gene T315I mutation detection. Detection Significance:Detect the resistance mechanism of conventional targeted drugs in patients with chronic myeloid ...
by:XACT Robotics Ltd. based inCaesarea, ISRAEL
Combines image-guided planning and real-time monitoring with precise robotic insertion and S-Drive™ technology to deliver instruments to the desired target in the body with enhanced accuracy, consistency, and efficiency. ...
Manufactured by:Cellworks Research India Private Limited based inBangalore, INDIA
The Cellworks Platform biosimulates how a patient’s unique cancer will respond to therapies prior to treatment and identifies novel drug combinations for treatment-refractory patients. Therapy biosimulation is the ability to predict the phenotype response of a human cell to an external stimulus, such as a drug ligand or radiation. We utilize this technology, to determine a patient’s ...
Manufactured by:Eutilex Co.,Ltd. based inSeoul, SOUTH KOREA
Fully humanized therapeutic monoclonal antibody. This could convert type II macrophage to Type I. Anti-tumor efficacy of the antibody can be achieved by modulating tumor ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
DearDTI presents drug candidates with a good efficacy by predicting the binding affinity, based on information about the compound-protein ...
Manufactured by:Eutilex Co.,Ltd. based inSeoul, SOUTH KOREA
MVR CAR-T can be used against HLA-DR positive cancer, as well as B cell malignancy. The epitopes recognized by HLA-DR are not shed or internalized, enabling stable binding to human lymphoma cells. MVR CAR-T can also be used in patients who relapse after CD19 CAR-T treatment. Reduction of cytokine secretion due to selective killing of tumor ...
Manufactured by:Eutilex Co.,Ltd. based inSeoul, SOUTH KOREA
4th generation GPC3 CAR-T shows better efficacy compared to 2nd generation GPC3 CAR-T; Shows better efficacy for tumor clearance than 2nd generation GPC3 CAR-T in vivo; Clear anti-cancer efficacy in an orthotopic model; Smaller number of 4th generation GPC3 CAR-T required than other groups to remove ...
Manufactured by:Triastek based inNanjing, CHINA
Triastek's 3DuS-GR technology is designed for targeted drug delivery to the stomach, allowing the product to remain in the gastric region for a pre-determined duration. This system is capable of customizing drug release profiles to achieve either extended-release or pulsatile-release, thereby potentially enhancing the absorption of active pharmaceutical ingredients and increasing drug efficacy. ...
Manufactured by:Eutilex Co.,Ltd. based inSeoul, SOUTH KOREA
Fully humanized anti-human 4-1BB monoclonal antibody. Agonistic effect of EU101 promotes cytotoxic T lymphocyte response and it leads to eradication of ...
Manufactured by:Eutilex Co.,Ltd. based inSeoul, SOUTH KOREA
4-1BB mAb-based, tumor antigen targeting bispecific ...
Manufactured by:Bluesail Medical Co., Ltd based inZibo, CHINA
EXCEL is the first biodegradable polymer sirolimus eluting stent (BP-SES), being widely used in percutaneous coronary intervention (PCI) for patients with coronary atherosclerotic disease. A large number of evidence-based clinical data have demonstrated its safety and efficacy and more than a million patients have benefited since EXCEL launched in 2005. ...
Manufactured by:Vieworks Co., Ltd. based inAnyang-si, SOUTH KOREA
Premium Preclinical in vivo Fluorescent & Bioluminescent Imaging and Analysis System ...
by:Xiamen Spacegen Co., Ltd. based inxiamen, CHINA
Detection Gene:EGFR (covering exons 18, 19, 20 and 21, total 30 loci related to targeted drugs). Detection Significance:Guide the selection of ...
by:Xiamen Spacegen Co., Ltd. based inxiamen, CHINA
Detection Gene:K-ras (covering 21 loci related to targeted drugs). Detection Significance:Guiding the selection of KRAS G12C inhibitor , anti-EGFR and ...
Manufactured by:Gadelius Medical K.K. based inTokyo, JAPAN
This thrombus-removal catheter allows for selective imaging of the coronary arteries, and the infusion of drugs such as thrombolytic agents, with the guide wire left in place. It has a Rapid Exchange type catheter structure, making use of a soft tip with high guide wire followability. ...